AMAN SEC filings, in plain English
Everything Amanat Acquisition has filed with the SEC that we hold — 39 filings, newest first, 37 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: A Joint Filing Agreement attached as Exhibit A to a Schedule 13G beneficial ownership report. No SPAC operational mechanics altered. The filing solely executes Rule 13d-1(k)(1) to permit ADAR1 Capital Management, LLC and Daniel Schneeberger to submit one Schedule 13G on their combined behalf. It does not reset the May 18, 2028 redemption window, move trust account funds, approve extensions, advance a business combination, or reflect sponsor conduct shifts. Share counts, acquisition percentages, and cash positions are absent from this excerpt; those figures belong to the primary Schedule 13G form, which was not provided. Why it matters: This is a routine compliance annex. It confirms administrative coordination for SEC reporting but contains zero commercial, strategic, or financial data. No customer metrics, revenue projections, market size estimates, technology disclosures, partnership terms, litigation allegations, or personnel actions are cited. Because the document limits itself to procedural authorization, investors monitoring redemption behavior, trust accruals, or deal momentum gain no new substantive intelligence. The material relevance, if any, rests entirely on the undisclosed line items of the parent 13G schedule.
What changed: An amended Schedule 13G filing reporting aggregated beneficial ownership positions for affiliated entities within the Sculptor Capital fund family. The excerpt identifies five affiliated holders—Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, and Sculptor Capital Management, Inc.—as the reporting group. The provided text omits specific share counts, percentage thresholds, voting power allocations, and acquisition dates, but the /A designation indicates a mandatory update to a prior disclosure, typically reflecting a reaffirmation of passive intent or a minor reconciliation of positions across the funds. No data regarding redemption deadlines, trust distributions, target identification, or sponsor transactions appears in the text. Why it matters: This is a standard securities law compliance filing. Because it tracks passive institutional equity without disclosing control rights, tender offers, or merger negotiations, it carries no direct impact on Amanat Acquisition’s stated $10.04 per-share trust balance, its May 18, 2028 completion deadline, or investor redemption mechanics. The filing reflects portfolio accounting disclosures rather than strategic corporate action.
What changed: A Schedule 13G/A, functioning as a routine regulatory compliance exhibit for amended beneficial ownership disclosures. The filing text identifies Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl as reporting persons and references SEC accession number [0001172661-26-003531]. The filing updates holdings statements rather than recording transactional events. It contains no share quantities, percentage thresholds, acquisition prices, or trade dates to demonstrate a change in ownership position. Accordingly, it does not affect redemption mechanics, trust account balances, extension parameters, merger voting timelines, or sponsor conduct. References to a $10.04 trust/share value or a 2028-05-18 deadline derive solely from the submission header provided, not the filing body. Why it matters: Beyond listing three reporting entities, the document contains no substantive business, financial, or strategic claims. It discloses no target identification, pipeline development, customer concentration, revenue projections, market sizing, technology assessments, partnership arrangements, litigation matters, or executive appointments. As a passive ownership amendment, it fulfills standard SEC transparency requirements without signaling capital deployment, business combination progress, or changes to the sponsor’s fiduciary timeline. Monitoring should continue toward subsequent 13D/G updates, Form 8-Ks, or proxy filings for material operational or structural developments.
What changed: A Joint Filing Agreement (Exhibit 1) annexed to a Schedule 13G beneficial ownership report for Amanat Acquisition (AMAN), executed under Rule 13d-1(k) by Braided LP, Braided Management LLC, Alexander T. Karnal, and Brian J. Kreiter. The filing does not modify or announce adjustments to the SPAC mechanics relevant to investors. It leaves the redemption calendar intact, preserves the stated trust value per share ($10.04), maintains the business combination deadline (2028-05-18), and registers no change in sponsor behavior or extension posture. It solely confirms the continuing co-beneficial ownership of AMAN securities by the named parties and designates a single signatory for SEC compliance routing. Why it matters: For shareholders tracking a SEARCHING-stage vehicle, this exhibit functions as a routine holding verification rather than a strategic catalyst. It introduces no target shortlist, management interviews, lock-up modifications, or capital call notices. The document contains no attributed assertions regarding customer pipelines, revenue forecasts, market sizing, technology roadmaps, commercial partnerships, litigation exposure, or executive transitions; therefore, it provides no independent variable for trust recovery modeling, redemption threshold assessment, or extension voting calculation.
What changed: This document IS a routine compliance exhibit — specifically, a Form 10-Q quarterly report for Amanat Acquisition Corp. for the quarter ended June 30, 2026, containing unaudited condensed financial statements, management discussion, and executive certifications. This filing details Q2 2026 corporate standing. Regarding redemption mechanics and timing, Management states the per-share trust redemption value is $10.04 ($75,290,024 total); the Completion Window remains unextended at 24 months from the May 20, 2026 IPO closing, fixing a hard deadline of May 20, 2028. Deal progress remains dormant: Management states the Company has not entered into a definitive agreement with any target as of June 30, 2026. On sponsor conduct, the filing discloses the underwriter’s 45-day option expired unexercised on July 4, 2026, triggering forfeiture of 281,250 founder shares; the Sponsor continues remitting a $20,000 monthly administrative fee to itself, while the CFO’s pay is guaranteed up to $250,000 if a deal closes within 24 months. The underwriter concurrently waived the $2,250,000 deferred underwriting commission payable from trust upon potential termination. Regarding other substance, Management reports zero operating revenues, funded exclusively by $290,024 in non-operating interest income. The corporate strategy targets any sector, bounded by Nasdaq rules mandating a transaction value of at least 80% of trust assets and >50% voting control. Personnel oversight is certified by CEO Pavan Cheruvu and CFO Nicholas Fernandez, who assert effective internal controls with no reported litigation, partnerships, or material weaknesses. Why it matters: The $10.04 trust floor establishes the precise liquidation benchmark for public shareholders, while the unextended May 20, 2028 deadline locks in the campaign timeline. The forfeiture of 281,250 founder shares mathematically reduces sponsor dilution and aligns remaining equity interests with public investors. The $2,250,000 underwriter waiver protects trust solvency against termination, whereas the $250,000 CFO guarantee and ongoing $20,000/month sponsor fees structurally tie insider compensation to successful deal execution rather than mere SPAC survival. Zero revenue confirmation reinforces that valuation risk rests entirely on future acquisition selection, making diligence pace and target quality the sole drivers of shareholder outcome.
trust account, mandate language, redeemable shares +1nothing moved · 4 with no prior record of ours
- Trust account
- not previously extracted$75.3M
- Mandate language
- not previously extractedThe Company may pursue an acquisition opportunity in any bus…
- Redeemable shares
- not previously extracted7.50M
- Sponsor loans outstanding
- $134K · unchanged
The clause …“Assets 1,819,853 Long term prepaid insurance 111,333 Cash and investments held in Trust Account 75,290,024 TOTAL ASSETS $ 77,221,210 LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT”…
The clause “200,000,000 shares authorized; 300,000 shares issued and outstanding, excluding 7,500,000 shares subject to possible redemption 30 Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 2,156,250 shares issued and”…
The clause …“Company determines not to conduct an Initial Public Offering. The Company had borrowed $ 134,056 under the promissory note which was fully repaid subsequent to the closing of the Initial Public Offering on June 2, 2026. Borrowings under”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Schedule 13G joint filing agreement pursuant to Rule 13d-1(k) executed by Affinity Asset Advisors, LLC and Michael Cho. Per the agreement signed by Affinity Asset Advisors, LLC and Michael Cho, the parties established a joint reporting arrangement for future Schedule 13G amendments, with each accepting shared responsibility for timely submission while retaining individual liability for the completeness and accuracy of their own information. The filing discloses no aggregate share count, beneficial ownership percentage, or voting/disposition rights. It contains no reference to Amanat Acquisition’s trust account, leaves the $10.04 per share trust balance untouched, does not pause or alter the May 18, 2028 deadline, reports zero advancement toward a business combination during the SEARCHING phase, and identifies no shifts in sponsor conduct or corporate governance beyond the procedural joint filing setup. Why it matters: For investors monitoring redemption windows, trust preservation, or merger progress, the document carries no mechanical impact: the deadline timeline continues unadjusted, the trust value remains fixed at $10.04, and no sponsor or management actions modify the SEARCHING mandate. The only relevant detail pertains to potential institutional ownership aggregation, though the specific block size triggering the 13G threshold is omitted. Because Affinity Asset Advisors, LLC and Michael Cho made no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, the filing offers no fundamental update to Amanat Acquisition’s valuation thesis or liquidity expectations.
What changed: A Schedule 13D/A, identified in the filing header as a 'beneficial ownership report,' which functions as a routine regulatory amendment to update previous Section 13(d) disclosures when a person or group alters holdings exceeding five percent of a registrant's voting securities. The extracted text contains only the title line and a system notation reading 'Structured holder table not present in this XML variant.' No acquirer name, share count, transaction price, or effective amendment date appears in the provided text. Mechanically, a 13D/A indicates a post-initial filing adjustment to the >5% ownership threshold. For a search-phase SPAC, such an amendment typically reflects modified common equity or warrant positions held by founders, anchor investors, or coordinated groups. The document does not report alterations to any redemption calendar, trust distribution mechanics, extension proposals, or sponsor governance conduct. Why it matters: Because the required tabular schedule is omitted, investors cannot verify updated ownership percentages, calculate trailing economic exposure, or determine if any position crosses or drops below the statutory 5% reporting boundary that governs proxy solicitation rights. The amendment nonetheless signals ongoing positional activity that could affect future lock-up expirations, secondary trading liquidity, and sponsor alignment ahead of any target announcement. The text contains zero references to customer backlogs, contracted revenue, total addressable market sizing, commercialization strategies, proprietary technology, channel partnerships, pending litigation, or key personnel appointments. Without the numerical breakdown, the filing provides procedural transparency but yields no quantifiable inputs to stress-test against redemption triggers or enterprise valuation models.
What changed: A Form 4 insider ownership report submitted to the SEC for Amanat Acquisition Corp. According to the filing, Amanat Sponsor Holdings LLC (identified in the document as a 10% owner) reported no acquisitions, dispositions, or derivative securities exercises or cancellations. The trust value of $10.04 per share and the 2028-05-18 liquidation deadline remain untouched by this submission. Deal progress continues to be classified as SEARCHING, with no target acquisition, extension amendment, redemption window opening, or underwriter commitment disclosed in the text. Why it matters: For investors monitoring redemption calendars, trust stability, and sponsor conduct, the explicit certification of zero reported transactions confirms the sponsor’s equity stake has not been traded, pledged, or diluted. In a SEARCHING SPAC, a static Form 4 removes short-term liquidity overhang and indicates the sponsor is preserving capital alignment ahead of any future merger negotiation or extension vote. Because the filing introduces no timeline shifts, capital calls, or strategic pivots, it does not alter the trajectory toward the 2028-05-18 deadline or shift pressure on the $10.04 trust floor. Investors should treat the submission as a neutral compliance checkpoint; absent subsequent target announcements or extension filings, redemption dynamics and valuation mechanics remain unchanged until material corporate action is formally disclosed.
What changed: This document IS a Form 4 insider ownership report, a routine regulatory compliance exhibit filed to disclose changes in equity or derivative holdings by an issuer’s officers, directors, or principal stockholders. According to the filing text, the document reports no mechanical shifts bearing on redemption deadlines, trust value, extension votes, deal progress, or sponsor conduct. It states that Reporting Person Kulkarni Sandeep Chidambar—identified as a director, Director and Chairman, and 10% owner—has recorded ‘No non-derivative transactions or holdings reported.’ Beyond this administrative confirmation of zero transactional activity, the document contains no additional substance: it makes no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel adjustments. Why it matters: For investors tracking redemption mechanics, trust continuity, extension timelines, de-spacings, and sponsor behavior, this filing establishes a transactional baseline: the chairman and 10% stakeholder neither accumulated nor divested securities during the reporting window. In a SPAC maintaining a SEARCHING designation, the null report indicates no shift in capital alignment or insider signaling ahead of any future deadline or trust distribution. While it updates neither the redemption calendar nor the trust composition, it documents stable sponsor positioning and provides a benchmark for monitoring subsequent insider trades.
What changed: A Joint Filing Agreement (Exhibit 99.1) submitted as part of an amended Schedule 13G, formally consolidating the Section 13 reporting obligations of RP Investment Advisors LP and RP Select Opportunities Master Fund Ltd. under the Securities Exchange Act of 1934. The document establishes a shared filing protocol for two affiliated investment vehicles governed by RP Investment Advisors GP Inc., executed by Chief Executive Officer Richard Pilosof. As this excerpt contains only the procedural agreement and not the primary Schedule 13G data pages, no revised share counts, ownership percentages, or acquisition purpose statements are presented. Consequently, no alteration is documented for AMAN’s redemption window, $10.04 per share trust balance, 2028-05-18 liquidation deadline, or ongoing searching status. The SPAC’s operational timeline, sponsor fiduciary commitments, and business combination pipeline remain untouched by this filing. Why it matters: The agreement reveals institutional alignment between two funds sharing the same general partner, indicating a coordinated reporting structure that may simplify or consolidate future proxy voting and shareholder communications around any eventual proposed transaction. For investors monitoring redemption mechanics and block positioning, this clarifies how affiliated capital pools will aggregate their public disclosures ahead of a special meeting. Because the submission is strictly administrative and omits the substantive Schedule 13G body, it provides no actionable intelligence on redemption volume, trust yield, extension voting thresholds, or deal progression. Tracking the actual share quantity and filing date triggers requires the accompanying Schedule 13G form itself.
What changed: A Joint Filing Agreement (Exhibit I) appended to a Schedule 13G/A, executed on July 31, 2026, by Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, confirming they will submit a single amended Schedule 13G to report combined beneficial ownership of Amanat Acquisition Corp Class A Ordinary Shares (par value $0.0001 per share) pursuant to SEC rules. According to the filing agreement signed by Global General Counsel Gil Raviv on behalf of the corporate filers and by Israel A. Englander individually, the undersigned parties authorize consolidated regulatory disclosure under Rule 13d-1(k). The exhibit discloses no updated share quantities, acquisition timestamps, or transaction pricing, meaning there are no alterations to the SPAC’s trust composition, redemption mechanics, or business combination timetable introduced by this submission. Why it matters: This routine compliance attachment confirms aggregated institutional positioning by Millennium-affiliated entities but contains zero substantive commentary on target acquisition progress, sponsor conduct, customer relationships, revenue projections, market sizing, technological capabilities, partnership arrangements, litigation exposure, or executive personnel changes. Because the document furnishes neither operational metrics nor forward-looking statements, it provides no actionable intelligence for calculating redemption yields, assessing extension vote triggers, or evaluating sponsor fiduciary behavior. Investors receive only a standardized confirmation of shared beneficial ownership tracking.
What changed: Routine compliance exhibit (Form 10-Q Quarterly Report). The registrant states via Subsequent Events disclosure that on May 20, 2026, it consummated an Initial Public Offering of 7,500,000 Class A Ordinary Shares at $10.00 per share, generating $75,000,000 in gross proceeds. The filing further notes that $75,000,000 was deposited into the Trust Account upon closing. Management indicates that the entity has established a 24-month Completion Window from the IPO date to finalize a Business Combination. Why it matters: These disclosures dictate the economic mechanics for public investors: the Trust Account balance of $75,000,000 establishes the initial redemption floor. The 24-month deadline fixes the expiration of the search period, after which liquidation procedures trigger. Regarding sponsor conduct, the registrant discloses a $20,000 per month administrative support agreement commencing May 18, 2026, and notes that the Sponsor, officers, and directors have contractually waived redemption rights for their Founder and Private Placement Shares. Deal progress remains static; management confirms the company has not selected a target nor engaged in substantive discussions regarding an initial Business Combination.
What changed: A Joint Filing Agreement (Exhibit 99.1) attached to a Schedule 13G beneficial ownership report, executed pursuant to Section 13 and Section 16 of the Securities Exchange Act of 1934. According to the joint filing agreement dated June 16, 2026, RP Investment Advisors LP and RP Select Opportunities Master Fund Ltd. authorized centralized disclosure administration, permitting both entities to submit a single Schedule 13G while preserving independent compliance duties. The exhibit was executed by Richard Pilosof in his capacity as Chief Executive Officer of RP Investment Advisors LP. The document contains no references to SPAC AMAN’s redemption schedule, trust value, proposed business combination deadline, extension procedures, merger progress, or sponsor behavior. No shift in beneficial ownership percentage, acquisition timing, or voting posture is disclosed within this exhibit; those data points are entirely absent. Why it matters: The joint filing confirms coordinated institutional positioning behind Amanat Acquisition, indicating that RP Investment Advisors LP and RP Select Opportunities Master Fund Ltd. collectively meet the Section 13(d) reporting threshold and have consolidated their regulatory footprint under Richard Pilosof’s executive direction. For investors monitoring redemption pressure, extension votes, or sponsor alignment ahead of the relevant business combination window, this document establishes a known blockholder base but provides zero visibility into share counts, tender intentions, or liquidity dynamics. Subsequent 13G/D amendments from these parties will dictate whether this affiliate group intends to passively hold, seek board representation, or participate in future redemption elections, directly informing capital structure stress tests and governance risk assessments.
What changed: A Joint Filing Agreement (Exhibit 99.1) attached to a Schedule 13D beneficial ownership report, dated June 11, 2026. This filing contains no updates to redemption deadlines, trust value mechanics, extension timelines, deal progress, or sponsor conduct. It is a routine compliance exhibit confirming that Amanat Sponsor Holdings LLC and Sandeep Kulkarni have agreed, pursuant to Rule 13(d)(1)(k), to file a single Schedule 13D on behalf of both parties to disclose their collective beneficial ownership of Amanat Acquisition Corp Class A ordinary shares. The agreement explicitly states it may be terminated by either party upon one week’s prior written notice or a mutually consented shorter period. Why it matters: No substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel are present in this document; the terms described are solely contractual provisions stated by the Filers within the exhibit itself. For investors tracking SPAC mechanics, this exhibit signals regulatory alignment between the sponsor entity and its Managing Member, which often accompanies unified voting arrangements or block positioning ahead of the 2028-05-18 deadline or any proposed business combination. Because this is only the supporting joint filing agreement, the actual share counts, acquisition purposes, and identity-of-interest disclosures that dictate redemption or conversion behavior remain in the primary Schedule 13D statement, which is not included here.
What changed: A Schedule 13G beneficial ownership report identifying six affiliated Sculptor Capital entities as holders of Amanat Acquisition securities. This filing discloses no operational or financial updates regarding Amanat Acquisition. It contains only holder names and SEC receipt metadata. Regarding redemption mechanics, trust valuation, extension windows, deal progress, or sponsor conduct, the text provides zero quantitative data on share counts, percentage ownership, acquisition dates, voting/investment power changes, or stated transaction purposes. Without these mandated disclosures, the filing offers no visibility into how institutional accumulation may impact per-share trust distributions, alter shareholder vote thresholds ahead of the announced deadline, or indicate sponsor runway pressures. Why it matters: Schedule 13G filings typically mark the threshold where passive or active institutional capital crosses into significant economic exposure, often preceding merger speculation or proxy activity. While this specific excerpt flags Sculptor Capital’s involvement, the absence of disclosure language prevents assessment of whether these positions represent long-term trust preservation, targeted warrant/call option positioning, or preparatory accumulation for a forthcoming business combination announcement. Until the complete filing—including exact security classes, transaction dates, and purpose statements—is reviewed, investors cannot determine if this ownership shift materially changes liquidity dynamics, redemption floor calibration, or partnership negotiations with potential targets.
What changed: Form 8-K current report confirming the consummation of the initial public offering and private placement, accompanied by an audited balance sheet and explanatory notes dated May 20, 2026. According to the registrant, the Company completed its IPO on May 20, 2026, selling 7,500,000 Class A ordinary shares at $10.00 per share for $75,000,000 in gross proceeds. Simultaneously, the Company sold 300,000 private placement shares to Amanat Sponsor Holdings LLC for $3,000,000. Audited financial statements show $75,000,000 was deposited into the trust account as of May 20, 2026, leaving $2,224,975 in operating cash and recording $2,857,791 in total liabilities, which includes a $2,250,000 deferred underwriting fee. Management stated the Company has not identified a business combination target or engaged in substantive negotiations. The filing establishes a 24-month completion window from the IPO close. The underwriters hold an unexercised 45-day option for up to 1,125,000 additional shares. Separately, the sponsor was allocated 2,156,250 founder shares, of which 300,000 were transferred to executives and independent directors at $3.00 per share ($900,000 fair value), vesting over 24 months. An administrative support agreement requires $20,000 monthly payments to the sponsor, and a related-party promissory note carries a $134,056 outstanding balance. Why it matters: This filing sets the mechanical baseline for public investors: it locks in the initial trust account at $75,000,000 ($10.00 per share), dictating the maximum redemption value before interest or tax deductions apply. The confirmed 24-month deadline triggers the mandatory liquidation sequence if no merger occurs, at which point the underwriter waives its $2,250,000 deferred commission to preserve trust funds for redeeming shareholders. The transfer of 300,000 founder shares and the $20,000 monthly administrative fee structure align sponsor and management compensation with the search timeline, while the absence of a target confirms the entity remains in a pre-deal phase. Executive retention clauses tied to these equity awards and the $10.00 conversion exercise price further bind leadership to the completion window.
What changed: Schedule 13G beneficial ownership report. This document is a Schedule 13G beneficial ownership report identifying Great Point Partners, LLC, Dr. Jeffrey R. Jay, M.D., and Ms. Lillian Nordahl as reporting persons. Concerning redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, the filing introduces no modifications to the stated deadline, does not alter the reported trust balance per share, proposes no extension mechanisms, advances no acquisition pipeline, and makes no reference to managerial actions or sponsor behavior. Beyond holder identification, the excerpt contains no substantive disclosures regarding prospective targets, commercial contracts, revenue streams, addressable markets, technological capabilities, alliance frameworks, ongoing disputes, or executive appointments. As a static registration of passive equity positions filed under Exchange Act rules, it confirms baseline retail and institutional presence in a searching-stage vehicle but delivers no operational intelligence to time capital withdrawals or evaluate sponsorship performance. Why it matters: Investors monitoring the SPAC will find no procedural triggers embedded in this filing; it neither accelerates redemption timelines nor validates management’s pursuit of a business combination. Its sole utility lies in confirming that additional parties have crossed the statutory beneficial ownership threshold, requiring Securities and Exchange Commission transparency compliance without affecting underlying asset liquidity or merger contingency planning.
What changed: A Joint Filing Agreement executed on May 22, 2026, attached to a Schedule 13G beneficial ownership report under Rule 13d-1(k). It formally authorizes Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander to submit a single regulatory disclosure on their collective beneficial ownership of Class A Ordinary Shares of Amanat Acquisition Corp., par value $0.0001 per share. The filing discloses no modifications to shareholder redemption windows, trust account distributions, extension procedures, or merger pipeline activity. Attributed exclusively to the joint filers and executed by Gil Raviv, Global General Counsel, and Israel A. Englander, the agreement establishes a procedural conduit for a unified SEC submission. It contains zero claims regarding target identification, customer contracts, revenue streams, market positioning, proprietary technology, strategic partnerships, active litigation, or executive appointments. The sole numerical parameter present is the stated par value of $0.0001 per share. Why it matters: The instrument confirms coordinated beneficial ownership reporting among Millennium-affiliated vehicles but delivers no operational, financial, or structural updates relevant to liquidation timelines, acquisition execution, or sponsor fiduciary actions. For holders monitoring exit mechanics, it indicates a passive or aligned block position without triggering tender events, altering voting thresholds, or modifying the underlying trust composition. The complete absence of commercial commentary or timeline shifts leaves existing development schedules and redemption parameters unchallenged by this submission, rendering it a routine reporting convenience rather than a catalyst for investor decision-making.
What changed: Form 4 — insider ownership report. In its own terms, this is a Form 4 insider ownership report. On SPAC mechanics, it records zero changes to the 2028-05-18 liquidation deadline, extension procedures, target acquisition progress, or trust distribution calculations. Regarding sponsor and insider conduct, the filing discloses that director and chairman Sandeep Chidambar Kulkarni, identified as a 10% owner, completed an open-market purchase on 2026-05-20 for 300,000 shares, leaving him with exactly 300,000 shares post-transaction. The document contains no further substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or executive personnel. Accession number 0001213900-26-060703 was filed on 2026-05-22. Why it matters: A chairman’s direct open-market purchase during a SEARCHING phase can signal internal alignment with acquisition timelines or provide incidental price support, yet the disclosure lacks operational context or target specificity. Because the transaction bypasses the trust account and occurs in secondary markets, it does not mechanically affect shareholder redemption rights, alter the trust-per-share balance of $10.04, or trigger extension provisions. The filing serves as a conduct metric rather than a structural catalyst; investors tracking the 2028-05-18 deadline should monitor for subsequent prospectus amendments or proxy filings that would convert insider accumulation into concrete deal progress.
What changed: Form 4 — insider ownership report. This document is a Form 4 — insider ownership report. Per the filing, Amanat Sponsor Holdings LLC executed an open-market purchase of 300,000 shares on May 20, 2026, bringing its reported post-transaction holding to 300,000 shares. Bearing on SPAC mechanics, the submission records no modifications to redemption deadlines, trust account valuation, merger agreement execution, or extension filings. Aside from sponsor conduct, the document contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: Sponsor accumulation filed on a Form 4 increases voting concentration and economic exposure without disturbing public trust balances, redemptions, or business combination timelines. For investors tracking a search-stage SPAC, the disclosed open-market block establishes a baseline of sponsor alignment and capital commitment ahead of target identification, while confirming that public shareholder liquidity mechanics remain structurally unchanged.
What changed: Form 8-K current report confirming the May 18, 2026 consummation of Amanat Acquisition Corp's initial public offering and executing its foundational corporate, trust, and underwriting agreements. Mechanics update: The filing records the sale of 7,500,000 Class A ordinary shares at $10.00 per share, generating $75,000,000 in gross proceeds, plus a concurrent $3,000,000 private placement of 300,000 shares to Amanat Sponsor Holdings LLC. Proceeds totaling $75,000,000 were deposited into a U.S.-based trust account administered by Continental Stock Transfer & Trust Company. The charter mandates a 24-month window from the May 18, 2026 closing to consummate a business combination, after which public shares must be redeemed within ten business days using trust funds, less taxes and up to $100,000 for dissolution expenses. Sponsor conduct is locked via a Letter Agreement requiring vote alignment, 180-day lock-ups for founder shares, waiver of redemption rights on private placement shares, and a commitment to indemnify third-party claims to protect the trust floor. Underwriter Leerink Partners LLC receives a $0.30 per share deferred discount contingent on a successful combination, otherwise redistributable to public shareholders. Monthly administrative payments to the Sponsor are fixed at $20,000. Why it matters: Substance & Strategy: This establishes the baseline capital structure and timeline for all secondary market pricing and redemption calculus. According to the press release dated May 19, 2026, management intends to pursue targets in healthcare or healthcare-related industries, though the company has not initiated substantive discussions with any specific target. The board was constituted with independent directors (Ms. Rakhi Kumar, Mr. Brad Middlekauff, Mr. Patrick Crutcher) chaired by Dr. Sandeep C. Kulkarni and led operationally by CEO Dr. Pavan Cheruvu. For investors, the $75,000,000 trust cap defines the maximum liquidity pool, while the $20,000 monthly outflow to the sponsor and the $100,000 dissolution expense carve-out create measurable drag on the per-share trust value over the 24-month search period. The forfeiture clause for the underwriter's deferred discount aligns third-party advisor incentives strictly with deal completion rather than mere process initiation.
What changed: Form 424B4 prospectus registered under Securities Act Registration No. 333-295170, offering 7,500,000 Class A ordinary shares of Amanat Acquisition Corp., a Cayman Islands exempted blank check company incorporating January 13, 2026 to effect an initial business combination, disclosing no target selection and no substantive discussions with any potential acquisition candidate. The filing establishes public share redemption mechanics at $10.00 per share drawn from a U.S. trust account administered by Continental Stock Transfer Trust Company. Why it matters: Management attributes the firm’s healthcare and life sciences sourcing strategy to its executive team’s background in drug development, venture investing, and corporate governance. The prospectus states the team has founded or directed eight biotechnology companies, generated over $20 billion in combined entity value, completed five successful public listings, executed four prior SPAC, de-SPAC, or reverse merger transactions, and secured more than $1 billion across previous financings.
What changed: SEC Form 3 — initial statement of beneficial ownership of securities, filed on 2026-05-19 by Amanat Acquisition Corp. reporting on insider positions held by Director, Chairman, and identified 10% owner Kulkarni Sandeep Chidambar. The filing reports no non-derivative transactions or holdings adjustments. There is no change to sponsor equity composition, insider capital allocation, or trust account parameters that would modify the SPAC’s SEARCHING status, the documented $10.04 trust per share, or the 2028-05-18 redemption deadline. Why it matters: This document serves as a routine compliance anchor confirming baseline insider attribution without altering redemption mechanics, extension triggers, or deal progression. The filing itself designates the reporting person as a '10% owner', establishing that specific threshold at the time of disclosure, though no transactional movement occurred to shift sponsor alignment or capital deployment capacity. Because it contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel movements beyond the statutory titles listed, it provides no incremental signal for portfolio construction or deadline tracking. Investors should monitor subsequent Forms 4 or 5 for actual transactional evidence of sponsor conduct rather than treating this static initial report as a catalyst.
What changed: A SEC Form 3 — insider ownership report. According to the filing, director MIDDLEKAUFF W BRADFORD reported no non-derivative transactions or holdings. No updates were provided regarding the SPAC’s 2028-05-18 redemption deadline, trust account mechanics, or business combination progress. The document does not contain claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel changes. Why it matters: This routine compliance exhibit establishes a statutory baseline for Section 16 insider reporting. Tracking director equity positions helps investors gauge management alignment during Amanat Acquisition’s search phase, particularly as the liquidation deadline approaches. While this submission reflects zero trading activity and introduces no new operational data, it confirms ongoing regulatory transparency and creates a verifiable reference point for all future insider movements that would influence shareholder confidence prior to a target announcement.
What changed: Form 3 insider ownership report / a routine compliance exhibit. The filing identifies Fernandez Nicholas, Chief Financial Officer, as the reporting person and explicitly states there are no non-derivative transactions or holdings reported. Why it matters: This routine compliance exhibit confirms zero change in insider equity, leaving the SEARCHING status, $10.04 per-share trust balance, and 2028-05-18 extension deadline entirely unaffected. It contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel beyond the reporting designation, and attributes no operational developments or sponsor conduct updates to any party.
What changed: SEC Form 3, an initial insider ownership compliance report. According to the Form 3 filed on 2026-05-19, Cheruvu Pavan reported no non-derivative transactions or holdings. The submission leaves the trust account mechanics, redemption calendar, extension provisions, and business-combination timeline entirely unaffected. Why it matters: Form 3 filings establish the legal baseline for insider equity positions, which investors monitor to assess sponsor conduct, management alignment, and potential conflicts before redemption deadlines. This report, attributed directly to the chief executive officer and director, confirms zero reported common stock positions, meaning the named insider currently holds no direct economic exposure to the trust or public share price. That structural neutrality informs how the company's governance team is evaluated during the remaining search period and future holder votes.
What changed: SEC Form 3, an initial statement of beneficial ownership by an insider. Per the Form 3 filing, director Kumar Rakhi reported holding zero non-derivative shares and recording no non-derivative transactions in Amanat Acquisition Corp. This submission introduces no alterations to insider equity positions, no adjustments to the public trust ($10.04 per share), and no modifications to the business combination deadline of 2028-05-18. The report signifies no sponsorship-funded accumulation, no extension-voting alignment shifts, and no direct signaling regarding liquidity drains or redemption pressure. Why it matters: By establishing a zero-baseline insider position through the filing, investors gain a clean reference point for tracking future management skin-in-the-game ahead of the 2028-05-18 cutoff. With no disclosed stock movements, there is no observable change in sponsor conduct, deal-pacing incentives, or target-selection urgency that would typically alter redemption calculus or trust preservation strategies. The trust remains intact at $10.04 per share as recorded, and shareholder redemption mechanics proceed unimpacted by this submission.
What changed: This filing is a Form 3 — insider ownership report, functioning as a routine compliance exhibit. The filing states that reporting person Crutcher Patrick J (director) recorded 'No non-derivative transactions or holdings reported.' Regarding the requested mechanics, this zero-activity disclosure means no insider equity movements, warrant or dollar exercises, or capital structure adjustments occurred. It does not modify the redemption calendar, trust value accounting, extension voting window, or acquisition progression. Why it matters: For investors tracking redemption deadlines, trust value, extensions, deal progress and sponsor conduct, a Form 3 with explicitly reported zero transactions confirms the named director has not altered his registered positions during the covered window. In a SEARCHING-stage SPAC, the absence of disclosed purchases, sales, or derivative activity signals no shift in management's financial alignment or risk exposure ahead of potential target identification or shareholder votes. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; all assertions derive exclusively from the regulatory form itself, which references accession number 0001213900-26-059028 and document classification 3.
What changed: In its own terms, this is a Form 3 initial statement of beneficial ownership filed by Amanat Sponsor Holdings LLC, cataloging a 10% equity stake in Amanat Acquisition Corp. and explicitly stating 'No non-derivative transactions or holdings reported.'. Regarding the mechanics tracked by SPAC investors, nothing changed. The filing reports zero movement in direct or derivative positions, provides no data on the redemption timeline, gives no indication of trust value fluctuations, announces no extension proposal or shareholder vote, identifies no business combination target or due diligence milestone, and discloses no sponsor conduct adjustments affecting capital deployment or shareholder liquidity. Why it matters: Because the report is procedurally complete yet substantively empty, it generates no verifiable claims about customer pipelines, contracted revenue, market sizing, corporate strategy, intellectual property, partnership frameworks, litigation posture, or personnel rotations. Every disclosed detail—that the reporting person holds a 10% interest and executed no transactions—was authored by the sponsor in this routine compliance exhibit. The static record leaves redemption pricing, extension probability, and deal acceleration entirely dependent on future managerial disclosures rather than insider trading signals.
What changed: A Form 8-A filing for the registration of Class A ordinary shares pursuant to Section 12(b) of the Securities Exchange Act of 1934, classified strictly as a routine exchange listing registration. This document reports no alterations to redemption deadlines, trust account valuations, extension mechanisms, merger target progression, or sponsor conduct. It simply confirms the SEC registration and Nasdaq listing of Class A ordinary shares, par value $0.0001 per share. Why it matters: For tracking purposes, this filing functions as an administrative confirmation that completes the initial capital raise registration cycle, establishing public trading status before any business combination pursuit begins. It discloses no forward-looking commercial targets, customer data, revenue models, addressable market sizing, technology roadmaps, strategic partnerships, active litigation, or leadership transitions beyond the execution block. The filing is dated May 18, 2026, and personally attests through Chief Executive Officer Pavan Cheruvu.
What changed: Amendment No. 2 to Form S-1 Registration Statement (preliminary prospectus) filed to register the initial public offering of Class A ordinary shares by Amanat Acquisition Corp. This S-1/A serves as a post-effective finalization amendment, updating the registration statement with audited financial statements through February 13, 2026, independent accountant consents, and supplemental exhibit filings ahead of expected effectiveness, rather than introducing altered transaction mechanics. The prospectus confirms the public offering consists of 7,500,000 Class A ordinary shares priced at $10.00 per share, with the underwriter holding a 45-day option for up to 1,125,000 additional shares. Proceeds will be deposited into a U.S.-based trust account initially anticipated by the company to hold $10.00 per public share, invested in U.S. government treasury obligations or money market funds. The company outlines a 24-month completion window to effect an initial business combination, extendable by shareholder approval via special resolution, which automatically triggers a concurrent redemption right at the per-share trust balance for abstaining, voting, or non-voting shareholders. A statutory limitation restricts any single public shareholder group from redeeming more than 20% of the public shares sold in this offering without prior written consent. Founder shares were originally acquired by sponsor Amanat Sponsor Holdings LLC for $25,000 total (approximately $0.012 per share), with up to 281,250 shares subject to surrender if the over-allotment option is not fully exercised. The underwriter receives a $0.10 per share upfront discount and defers $0.30 per share in commissions ($2,250,000 aggregate, or $2,587,500 with full over-allotment), which are held in trust and forfeited entirely if the company liquidates without completing a merger. Why it matters: The filing establishes the definitive economic framework, redemption parameters, and conflict-of-interest landscape for pre-deal capital markets participants. Management discloses a targeted focus on healthcare and life science companies, highlighting prior tenures at entities like Zura Bio, Tourmaline Bio, and Liminatus Pharma, while simultaneously cautioning that historical performance does not guarantee future deal sourcing success or return on capital. The capital structure structurally advantages insiders: founders secured equity at roughly $0.012 per share, carry anti-dilution conversion mechanics that can expand their post-combination voting and economic stakes beyond the baseline 20%, and receive a recurring $20,000 per month administrative service fee alongside firm minimum compensation guarantees for executive leadership. These terms create immediate implied value dilution for public investors, with pro forma adjusted net tangible book value per share models projecting outlays ranging from approximately $2.32 to $10.44 per share depending on hypothetical redemption tranches. Notably, the deliberate omission of warrants eliminates traditional SPAC post-merger hedging overhang but also removes a built-in upside component for early buyers. The precise redemption cap, extension triggers, and over-allotment-based founder share forfeiture rules provide transparent liquidity boundaries while directly aligning sponsor retention incentives with the scale of capital successfully deployed.
What changed: A SEC correspondence (CORRESP) letter submitting a formal request for acceleration of the effective date for Registration Statement File No. 333-295170. Mechanically, the document provides zero updates on redemption deadlines, trust value, extension mechanisms, deal progress, or sponsor conduct. It does not reference trust valuations or shareholder redemption timelines. Why it matters: Beyond mechanics, the filing contains no substantive business disclosures: there are no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or additional personnel shifts. Chief Executive Officer Pavan Cheruvu remains the only named executive authorizing the submission.
What changed: This document is a correspondence filing (CORRESP) from underwriter Leerink Partners LLC, formatted as a formal acceleration request to the SEC’s Division of Corporation Finance for a registered public offering. No changes occur to redemption deadlines, trust value per share ($10.04), extension provisions, business combination progress, or sponsor conduct. According to Sean Pitt, Senior Managing Director at Leerink Partners LLC, the firm is invoking Rule 461 to accelerate the effective date of Amanat Acquisition Corp’s Form S-1 (initially filed April 17, 2026, File No. 333-295170) to 4:00 p.m. Why it matters: For investors tracking the capital raise sequence, this submission confirms the lead underwriter’s distribution readiness and anticipates a May 18, 2026 trading commencement. Although it does not adjust the stated 2028-05-18 liquidation deadline or alter shareholder redemption mechanics, it indicates the sponsor is actively moving toward public listing rather than pausing the search. Without a final prospectus or pricing supplement, the actual trust balance, underwriter spread, and over-allotment volume remain unconfirmed.
What changed: An exhibits-only S-1/A registration statement amendment that finalizes pre-IPO contractual frameworks, including the form of underwriting agreement, the Investment Management Trust Agreement, corporate governance charters, and a Code of Business Conduct and Ethics. This filing attaches definitive agreements that lock in the offering and trust mechanics ahead of the expected Nasdaq listing. It confirms the underwriting agreement with Leerink Partners LLC for 7,500,000 Class A Ordinary Shares at a public offering price of $10.00 per share, plus a 1,125,000-share over-allotment option. The trust agreement dictates an initial deposit of $75,000,000 of gross proceeds into a trust account maintained by Continental Stock Transfer & Trust Company, escalating to $86,250,000 if the over-allotment is exercised in full. It codifies the 24-month deadline to consummate a business combination, after which the company must liquidate and distribute trust funds pro rata to public shareholders, less taxes and up to $100,000 for dissolution expenses. The underwriting agreement introduces a deferred discount of $0.30 per ordinary share, payable only upon a successful combination; if no combination occurs within the timeframe, the underwriter forfeits this right and the trustee distributes the deferred discount pro rata to public shareholders. It also details an 80% fair market value test for any target business, a forfeiture schedule for the sponsor’s 2,156,250 founder shares (priced at $25,000 or approximately $0.012 per share) dependent on over-allotment exercise, and a hard cap on sponsor administrative compensation at $20,000 per month. Why it matters: These finalized terms remove ambiguity around liquidity, capital preservation, and sponsor alignment prior to the IPO. The $75,000,000 trust baseline and explicit 24-month liquidation trigger define the maximum redemption value and timeline risk for public shareholders. The shift of the $0.30-per-share deferred discount to public shareholders upon a missed deadline effectively increases the cash available for redemption in a failure scenario, but also underscores the cost of inaction. The 80% fair market value threshold and capped $20,000 monthly sponsor payouts establish clear guardrails against excessive dilution or administrative drain during the search period. Together, these exhibits confirm standard but binding mechanical protections that will govern the trust, redemption deadlines, and post-combination equity structure.
What changed: SPAC Initial Public Offering Registration Statement (Form S-1) with Preliminary Prospectus. Initial S-1 registration statement files for 7,500,000 Class A ordinary shares at a $10.00 public offering price. Establishes a $75,000,000 segregated trust account (pro-rata redemption value initially anticipated at $10.00 per share), a 24-month business combination completion window extendable up to a maximum of 36 months via shareholder vote, and outlines the sponsor's acquisition of 2,156,250 founder shares for $25,000 (~$0.012 per share) alongside a simultaneous $3,000,000 private placement of 300,000 shares. Codifies redemption rights, a 20% single-holdership redemption cap, deferred underwriting compensation, and 180-day founder share lock-ups. Why it matters: Defines the baseline investment thesis and economic mechanics for public capital: investors receive equity-only exposure without accompanying public warrants, establishing a clear $10.00-per-share redemption floor but introducing substantial immediate dilution given the nominal sponsor share cost. The filing explicitly links capital deployment to a life sciences/biotech sourcing mandate backed by management's documented prior de-SPAC track records, while structuring governance (corporate opportunity renunciation, extended voting windows, and insider non-redeeming commitments) to align sponsor incentives with deal execution within the prescribed timeframe.
What changed: A Division of Corporation Finance staff correspondence advising Amanat Acquisition Corp. that the SEC will not review its March 18, 2026 draft Form S-1 registration statement, while prescribing public filing timing rules and reaffirming management’s independent obligation to ensure disclosure accuracy. The filing introduces no alterations to redemption deadlines, trust value, extension provisions, or target acquisition mechanics. Why it matters: For investors tracking the $10.04 per-share trust balance and the 2028-05-18 liquidation deadline, the non-review stance removes the expectation of a formal comment period that could delay pricing, mandate restatements, or signal underlying risks, effectively transferring verification duty entirely to management and outside counsel.
What changed: Confidential draft Form S-1 registration statement and preliminary prospectus registering the initial public offering of 7,500,000 Class A ordinary shares. This filing establishes baseline SPAC mechanics rather than modifying existing terms. According to the draft prospectus, the trust account is initialized at $75,000,000 (stated as $10.00 per public share), administered by Continental Stock Transfer & Trust Company, with provisions authorizing up to $100,000 of accrued interest for dissolution expenses and permitting interest withdrawals solely for tax obligations. Why it matters: The baseline trust composition and the 24-month execution timeline impose strict capital deployment discipline, while the 20% redemption cap and automatic extension redemption rights structurally limit holdout leverage and preserve deal viability. Because the sponsor acquired founder shares at nominal cost and waived liquidation rights, the economic incentive heavily favors accelerating a combination within the window, despite the filing's acknowledgment of potential conflicts arising from board members' simultaneous fiduciary duties to other entities and broad corporate opportunity waivers.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.